HAKA: Routine Follow-Up at 1 Year After Hip- or Knee Arthroplasty: Wasting Resources or Appropriate Healthcare?
NCT ID: NCT06971757
Last Updated: 2025-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
1000 participants
INTERVENTIONAL
2025-07-01
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The HAKA trial consists of three different work packages (WPs). This trial (WP1) investigates the 1-year follow-up, WP2 examines the 10-year follow-up, and WP3 is a qualitative study exploring the experiences and perceptions of patients and healthcare professionals. The aim of the HAKA trial is to safely reduce routine follow-up appointments after total hip or knee arthroplasty and to revise current clinical guidelines accordingly.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perceptions of De-implementing Routine Follow-ups After Hip and Knee Arthroplasty
NCT07041528
HAKA: Routine Follow-up at 10 Years After Hip- or Knee Arthroplasty: Wasting Resources or Appropriate Healthcare?
NCT07070570
Questionnaire and Radiography for Prosthesis Follow-up
NCT03745976
Routine Follow up After Total Hip Arthroplasty Prior Periacetabular Osteotomy
NCT01657357
Comparison of the Restoration of Hip Biomechanical Parameters by CT Measurement Between the 3 Surgical Techniques: RSA/Minihip/THA - Hip Replacement: 3D Planning
NCT06272422
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Routine Follow-Up (RFU)
X-ray and clinical visit within 3 months and at 1 year after surgery.
Routine Follow-Up (RFU)
Standard follow-up care with scheduled X-ray and clinical visit at 3 months and 1 year after surgery.
Check-Up on Demand (COD)
X-ray and clinical visit within 3 months and only at 1 year when requested by the patient or healthcare provider.
Check-Up on Demand (COD)
Follow-up care with scheduled X-ray and clinical visit at 3 months and only at 1 year if requested.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Routine Follow-Up (RFU)
Standard follow-up care with scheduled X-ray and clinical visit at 3 months and 1 year after surgery.
Check-Up on Demand (COD)
Follow-up care with scheduled X-ray and clinical visit at 3 months and only at 1 year if requested.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for primary THA or TKA surgery
* Age 50 years or older at the time of THA or TKA
* Capable and willing to complete questionnaires
* Proficient in Dutch or English
* Willing to provide informed consent
Exclusion Criteria
* Scheduled for hip or knee revision arthroplasty, except a conversion from unicompartmental knee arthroplasty to TKA or from hip hemiarthroplasty/resurfacing to THA
* Already participating in this study due to a previous hip or knee surgery
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Reinier Haga Orthopedisch Centrum
OTHER
Tergooi MC
UNKNOWN
JointResearch
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
OLVG
Amsterdam, , Netherlands
Amphia
Breda, , Netherlands
Deventer Ziekenhuis
Deventer, , Netherlands
Admiraal de Ruyter Ziekenhuis
Goes, , Netherlands
Martini Ziekenhuis
Groningen, , Netherlands
Tergooi MC
Hilversum, , Netherlands
Canisius Wilhelmina Ziekenhuis
Nijmegen, , Netherlands
ZorgSaam Zeeuws Vlaanderen
Terneuzen, , Netherlands
RHOC
Zoetermeer, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10330042310003
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
NL-009246
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.